Press Releases

Cell Source to Present at the 2015 Marcum MicroCap Conference

NEW YORK, NY -- (Marketwired) -- 05/22/15 -- Cell Source, Inc. (OTCQB: CLCS), a biotechnology company focused on developing cell therapy treatments based on immunotherapy and regenerative medicine, announced today that it will present at the 2015 Marcum MicroCap Conference on Thursday, May 28th, 2015 in New York City at the Grand Hyatt Hotel.

The Company's presentation by Mr. Itamar Shimrat, CEO is scheduled to begin at 10:00 a.m. ET and will be available via a live webcast. To access the webcast, go to http://wsw.com/webcast/marcum3/CLCS.

About Cell Source, Inc.

Cell Source, Inc. (OTCQB: CLCS) a biotechnology company focused on developing cell therapy treatments based on immunotherapy and regenerative medicine.

For more information go to www.cell-source.com.

About the Marcum MicroCap Conference

The annual Marcum MicroCap Conference is a showcase for public companies with less than $500 million in market capitalization. This year's keynote speaker will be Richard S. Fuld, Jr., Chairman of Matrix Advisors and former Chairman of Lehman Brothers. The conference attracts fund managers and high net worth investors focusing on small cap equities. Over 2,000 participants from all segments of the microcap market attend each year, including senior management, finance and legal executives, venture and lower middle-market private equity investors, institutional investors, directors, investment bankers, buy- and sell-side analysts, and service providers to the microcap marketplace.

About Marcum LLP

Marcum LLP is one of the largest independent public accounting and advisory services firms in the United States. Ranked #15 nationally, Marcum LLP offers the resources of 1,300 professionals, including over 160 partners, in 23 offices worldwide. Headquartered in New York for more information on Marcum go to http://www.marcumllp.com.

CELL SOURCE, INC. INVESTOR, MEDIA & GENERAL CORPORATE CONTACT:
Phone: +1 (646) 612-7554
Toll Free: +1 (888) 315-4650
Email: info@cell-source.com

Source: Cell Source, Inc.